{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T20:02:51Z","timestamp":1785355371816,"version":"3.55.0"},"reference-count":43,"publisher":"Begell House","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Crit Rev Eukaryot Gene Expr"],"published-print":{"date-parts":[[2026]]},"abstract":"<p>&lt;b&gt;Background:&lt;\/b&gt; Hepatocellular carcinoma (HCC) remains a global health challenge due to the lack of reliable early diagnostic markers and therapeutic targets. While CD58 is implicated in immune modulation and cancer progression, its role in HCC has not been fully explored.\n\n&lt;b&gt;Methods:&lt;\/b&gt; Bioinformatics analysis was performed to assess CD58 expression and its clinical significance. Immunohistochemistry was conducted on tissue microarrays to validate CD58 expression, while enzyme-linked immunosorbent assay was used to measure soluble CD58 levels in HCC serum. A nomogram was constructed to predict overall survival, and decision curve analysis along with area under the ROC curve were applied to evaluate its diagnostic value. Additionally, serum trace elemental levels were analyzed using inductively coupled plasma atomic emission spectroscopy to explore their relationship with sCD58.\n\n&lt;b&gt;Results:&lt;\/b&gt; CD58 was overexpressed in human HCC tissues and its expression was associated with age and hepatitis status. For HCC patients, CD58 was identified as an independent prognostic factor. Furthermore, CD58 was positively correlated with T cell infiltration in HCC tissues. The levels of sCD58 were elevated in HCC serum and showed significant diagnostic potential. Notably, sCD58 correlated with copper levels, providing new insights into its role in HCC progression.\n\n&lt;b&gt;Conclusion:&lt;\/b&gt; CD58 is a promising diagnostic and prognostic biomarker for HCC, and targeting CD58 may offer novel therapeutic strategies. The correlation between sCD58 and copper levels suggests that copper could play a key role in HCC pathogenesis.<\/p>","DOI":"10.1615\/critreveukaryotgeneexpr.2026063933","type":"journal-article","created":{"date-parts":[[2026,5,26]],"date-time":"2026-05-26T19:02:57Z","timestamp":1779822177000},"page":"29-45","source":"Crossref","is-referenced-by-count":0,"title":["CD58: A Promising Diagnostic and Prognostic Biomarker for Hepatocellular Carcinoma"],"prefix":"10.1615","volume":"36","author":[{"given":"Rong","family":"Cui","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanmei","family":"Gu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yingying","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gangli","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaomei","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Puyi","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yujie","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yumin","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"613","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"Rumgay H, Arnold M, Ferlay J, Lesi O, Cabasag CJ, Vignat J, Laversanne M, McGlynn KA, Soerjomataram I. Global burden of primary liver cancer in 2020 and predictions to 2040. J Hepatol. 2022;77(6):1598-\u0080\u0093606.","DOI":"10.1016\/j.jhep.2022.08.021"},{"key":"2","doi-asserted-by":"crossref","unstructured":"Tan EY, Danpanichkul P, Yong JN, Yu Z, Tan DJH, Lim WH, Koh B, Lim RYZ, Tham EKJ, Mitra K, Morishita A, Hsu Y-C, Yang JD, Takahashi H, Zheng M-H, Nakajima A, Ng CH, Wijarnpreecha K, Muthiah MD, Singal AG, Huang DQ. Liver cancer in 2021: Global Burden of Disease study. J Hepatol. 2025;82(5):851-\u0080\u009360.","DOI":"10.1016\/j.jhep.2024.10.031"},{"key":"3","doi-asserted-by":"crossref","unstructured":"Wang Q, Liu B, Qiao W, Li J, Yuan C, Long J, Hu C, Zang C, Zheng J, Zhang Y. The dynamic changes of AFP from baseline to recurrence as an excellent prognostic factor of hepatocellular carcinoma after locoregional therapy: A 5-year prospective cohort study. Front Oncol. 2021;11:756363.","DOI":"10.3389\/fonc.2021.756363"},{"key":"4","doi-asserted-by":"crossref","unstructured":"Cao Z, Cheng Y, Wang J, Liu Y, Yang R, Jiang W, Li H, Zhang X. HBP1-mediated transcriptional repression of AFP inhibits hepatoma progression. J Exp Clin Cancer Res. 2021;40(1):118.","DOI":"10.1186\/s13046-021-01881-2"},{"key":"5","doi-asserted-by":"crossref","unstructured":"Chen T, Dai X, Dai J, Ding C, Zhang Z, Lin Z, Hu J, Lu M, Wang Z, Qi Y, Zhang L, Pan R, Zhao Z, Lu L, Liao W, Lu X. AFP promotes HCC progression by suppressing the HuR-mediated Fas\/FADD apoptotic pathway. Cell Death Dis. 2020;11(10):822.","DOI":"10.1038\/s41419-020-03030-7"},{"key":"6","doi-asserted-by":"crossref","unstructured":"Pang B-Y, Leng Y, Wang X, Wang Y-Q, Jiang L-H. A meta-analysis and of clinical values of 11 blood biomarkers, such as AFP, DCP, and GP73 for diagnosis of hepatocellular carcinoma. Ann Med. 2023;55(1):42-\u0080\u009361.","DOI":"10.1080\/07853890.2022.2153163"},{"key":"7","doi-asserted-by":"crossref","unstructured":"Itzhaky D, Raz N, Hollander N. The glycosylphosphatidylinositol-anchored form and the transmembrane form of CD58 associate with protein kinases. J Immunol. 1998;160(9):4361-\u0080\u00936.","DOI":"10.4049\/jimmunol.160.9.4361"},{"key":"8","doi-asserted-by":"crossref","unstructured":"Zhang Y, Liu Q, Liu J, Liao Q. Upregulated CD58 is associated with clinicopathological characteristics and poor prognosis of patients with pancreatic ductal adenocarcinoma. Cancer Cell Int. 2021;21(1):327.","DOI":"10.1186\/s12935-021-02037-0"},{"key":"9","doi-asserted-by":"crossref","unstructured":"Wu B, Zhan X, Jiang M. CD58 defines regulatory macrophages within the tumor microenvironment. Commun Biol. 2024;7(1):1025.","DOI":"10.1038\/s42003-024-06712-6"},{"key":"10","doi-asserted-by":"crossref","unstructured":"Guo R, Yu J, Guo Z. Virtual screening and binding analysis of potential CD58 inhibitors in colorectal cancer (CRC). Molecules. 2023;28(19).","DOI":"10.3390\/molecules28196819"},{"key":"11","doi-asserted-by":"crossref","unstructured":"Xu S, Wen Z, Jiang Q, Zhu L, Feng S, Zhao Y, Wu J, Dong Q, Mao J, Zhu Y. CD58, a novel surface marker, promotes self-renewal of tumor-initiating cells in colorectal cancer. Oncogene. 2015;34(12):1520-\u0080\u009331.","DOI":"10.1038\/onc.2014.95"},{"key":"12","doi-asserted-by":"crossref","unstructured":"Suo D, Gao X, Chen Q, Zeng T, Zhan J, Li G, Zheng Y, Zhu S, Yun J, Guan X-Y, Li Y. HSPA4 upregulation induces immune evasion via ALKBH5\/CD58 axis in gastric cancer. J Exp Clin Cancer Res. 2024;43(1):106.","DOI":"10.1186\/s13046-024-03029-4"},{"key":"13","doi-asserted-by":"crossref","unstructured":"Quastel M, Dustin M. The CD58-CD2 axis in cancer immune evasion. Nat Rev Immunol. 2022;22(7):409.","DOI":"10.1038\/s41577-022-00738-9"},{"key":"14","doi-asserted-by":"crossref","unstructured":"Miao B, Hu Z, Mezzadra R, Hoeijmakers L, Fauster A, Du S, Yang Z, Sator-Schmitt M, Engel H, Li X, Broderick C, Jin G, Gomez-Eerland R, Rozeman L, Lei X, Matsuo H, Yang C, Hofland I, Peters D, Broeks A, Laport E, Fitz A, Zhao X, Mahmoud MAA, Ma X, Sander S, Liu H-K, Cui G, Gan Y, Wu W, Xiao Y, Heck AJR, Guan W, Lowe SW, Horlings HM, Wang C, Brummelkamp TR, Blank CU, Schumacher TNM, Sun C. CMTM6 shapes antitumor T cell response through modulating protein expression of CD58 and PD-L1. Cancer Cell. 2023;41(10).","DOI":"10.1016\/j.ccell.2023.08.008"},{"key":"15","doi-asserted-by":"crossref","unstructured":"Xu X, Zhang Y, Lu Y, Zhang X, Zhao C, Wang J, Guan Q, Feng Y, Gao M, Yu J, Song Z, Liu X, Golchehre Z, Li L, Ren W, Pan-Hammarstr\u00f6m Q, Zhang H, Wang X. CD58 Alterations govern antitumor immune responses by inducing PDL1 and IDO in diffuse large B-cell lymphoma. Cancer Res. 2024;84(13):2123-\u0080\u009340.","DOI":"10.1158\/0008-5472.CAN-23-2874"},{"key":"16","doi-asserted-by":"crossref","unstructured":"Abdul Razak FR, Diepstra A, Visser L, van den Berg A. CD58 mutations are common in Hodgkin lymphoma cell lines and loss of CD58 expression in tumor cells occurs in Hodgkin lymphoma patients who relapse. Genes Immun. 2016;17(6):363-\u0080\u00936.","DOI":"10.1038\/gene.2016.30"},{"key":"17","doi-asserted-by":"crossref","unstructured":"Sali\u00e9 H, Wischer L, D'\u0080\u0099Alessio A, Godbole I, Suo Y, Otto-Mora P, Beck J, Neumann O, Stenzinger A, Schirmacher P, Fulgenzi CAM, Blaumeiser A, Boerries M, Roehlen N, Schulthei\u00df M, Hofmann M, Thimme R, Pinato DJ, Longerich T, Bengsch B. Spatial single-cell profiling and neighbourhood analysis reveal the determinants of immune architecture connected to checkpoint inhibitor therapy outcome in hepatocellular carcinoma. Gut. 2025;74(3):451-\u0080\u009366.","DOI":"10.1136\/gutjnl-2024-332837"},{"key":"18","doi-asserted-by":"crossref","unstructured":"Veldman J, Visser L, Huberts-Kregel M, Muller N, Hepkema B, van den Berg A, Diepstra A. Rosetting T cells in Hodgkin lymphoma are activated by immunological synapse components HLA class II and CD58. Blood. 2020;136(21):2437-\u0080\u009341.","DOI":"10.1182\/blood.2020005546"},{"key":"19","doi-asserted-by":"crossref","unstructured":"Ho P, Melms JC, Rogava M, Frangieh CJ, Po\u017aniak J, Shah SB, Walsh Z, Kyrysyuk O, Amin AD, Caprio L, Fullerton BT, Soni RK, Ager CR, Biermann J, Wang Y, Khosravi-Maharlooei M, Zanetti G, Mu M, Fatima H, Moore EK, Vasan N, Bakhoum SF, Reiner SL, Bernatchez C, Sykes M, Mace EM, Wucherpfennig KW, Schadendorf D, Bechter O, Shah P, Schwartz GK, Marine J-C, Izar B. The CD58-CD2 axis is co-regulated with PD-L1 via CMTM6 and shapes anti-tumor immunity. Cancer Cell. 2023;41(7).","DOI":"10.1016\/j.ccell.2023.05.014"},{"key":"20","doi-asserted-by":"crossref","unstructured":"Zeng H, Yu J, Wang H, Shen M, Zou X, Zhang Z, Liu L. Cancer ATF4-mediated CD58 endocytosis impairs anti-tumor immunity and immunotherapy. J Transl Med. 2025;23(1):225.","DOI":"10.1186\/s12967-025-06245-4"},{"key":"21","doi-asserted-by":"crossref","unstructured":"Westphal JR, Willems HW, Ruiter DJ, De Waal RM. Involvement of LFA-1\/ICAM and CD2\/LFA-3 in human endothelial cell accessory function. Behring Inst Mitt. 1993(92):51-\u0080\u009362.","DOI":"10.1016\/0966-3274(93)90045-A"},{"key":"22","doi-asserted-by":"crossref","unstructured":"Albert-Wolf M, Meuer SC, Wallich R. Dual function of recombinant human CD58: Inhibition of T cell adhesion and activation via the CD2 pathway. Int Immunol. 1991;3(12):1335-\u0080\u009347.","DOI":"10.1093\/intimm\/3.12.1335"},{"key":"23","doi-asserted-by":"crossref","unstructured":"Lossow K, Schwarz M, Kipp AP. Are trace element concentrations suitable biomarkers for the diagnosis of cancer? Redox Biol. 2021;42:101900.","DOI":"10.1016\/j.redox.2021.101900"},{"key":"24","doi-asserted-by":"crossref","unstructured":"Gurusamy K. Trace element concentration in primary liver cancers-\u0080\u0094A systematic review. Biol Trace Elem Res. 2007;118(3):191-\u0080\u0093206.","DOI":"10.1007\/s12011-007-0008-x"},{"key":"25","doi-asserted-by":"crossref","unstructured":"Himoto T, Masaki T. Current trends on the involvement of zinc, copper, and selenium in the process of hepatocarcinogenesis. Nutrients. 2024;16(4).","DOI":"10.3390\/nu16040472"},{"key":"26","doi-asserted-by":"crossref","unstructured":"Stepien M, Hughes DJ, Hybsier S, Bamia C, Tj\u00f8nneland A, Overvad K, Affret A, His M, Boutron-Ruault M-C, Katzke V, K\u00fchn T, Aleksandrova K, Trichopoulou A, Lagiou P, Orfanos P, Palli D, Sieri S, Tumino R, Ricceri F, Panico S, Bueno-de-Mesquita HBA, Peeters PH, Weiderpass E, Lasheras C, Bonet Bonet C, Molina-Portillo E, Dorronsoro M, Huerta JM, Barricarte A, Ohlsson B, Sj\u00f6berg K, Werner M, Shungin D, Wareham N, Khaw K-T, Travis RC, Freisling H, Cross AJ, Schomburg L, Jenab M. Circulating copper and zinc levels and risk of hepatobiliary cancers in Europeans. Br J Cancer. 2017;116(5):688-\u0080\u009396.","DOI":"10.1038\/bjc.2017.1"},{"key":"27","doi-asserted-by":"crossref","unstructured":"He F, Chang C, Liu B, Li Z, Li H, Cai N, Wang H-H. Copper (II) ions activate ligand-independent receptor tyrosine kinase (RTK) signaling pathway. Biomed Res Int. 2019;2019:4158415.","DOI":"10.1155\/2019\/4158415"},{"key":"28","doi-asserted-by":"crossref","unstructured":"Porcu C, Antonucci L, Barbaro B, Illi B, Nasi S, Martini M, Licata A, Miele L, Grieco A, Balsano C. Copper\/MYC\/CTR1 interplay: A dangerous relationship in hepatocellular carcinoma. Oncotarget. 2018;9(10):9325-\u0080\u009343.","DOI":"10.18632\/oncotarget.24282"},{"key":"29","doi-asserted-by":"crossref","unstructured":"L\u00f6tscher J, Mart\u00ed I L\u00edndez A-A, Kirchhammer N, Cribioli E, Giordano Attianese GMP, Trefny MP, Lenz M, Rothschild SI, Strati P, K\u00fcnzli M, Lotter C, Schenk SH, Dehio P, L\u00f6liger J, Litzler L, Schreiner D, Koch V, Page N, Lee D, Gr\u00e4hlert J, Kuzmin D, Burgener A-V, Merkler D, Pless M, Balmer ML, Reith W, Huwyler J, Irving M, King CG, Zippelius A, Hess C. Magnesium sensing via LFA-1 regulates CD8+ T cell effector function. Cell. 2022;185(4).","DOI":"10.1016\/j.cell.2021.12.039"},{"key":"30","doi-asserted-by":"crossref","unstructured":"Vardhana S, Dustin ML. Magnesium for T cells: Strong to the finish! Trends Immunol. 2022;43(4):277-\u0080\u00939.","DOI":"10.1016\/j.it.2022.02.004"},{"key":"31","doi-asserted-by":"crossref","unstructured":"Mayer B, Lorenz C, Babic R, Jauch KW, Schildberg FW, Funke I, Johnson JP. Expression of leukocyte cell adhesion molecules on gastric carcinomas: Possible involvement of LFA-3 expression in the development of distant metastases. Int J Cancer. 1995;64(6):415-\u0080\u009323.","DOI":"10.1002\/ijc.2910640611"},{"key":"32","doi-asserted-by":"crossref","unstructured":"Wang C, Cao F, Cao J, Jiao Z, You Y, Xiong Y, Zhao W, Wang X. CD58 acts as a tumor promotor in hepatocellular carcinoma via activating the AKT\/GSK-3\u00ce\u00b2\/\u00ce\u00b2-catenin pathway. J Transl Med. 2023;21(1):539.","DOI":"10.1186\/s12967-023-04364-4"},{"key":"33","doi-asserted-by":"crossref","unstructured":"Demetriou P, Abu-Shah E, Valvo S, McCuaig S, Mayya V, Kvalvaag A, Starkey T, Korobchevskaya K, Lee LYW, Friedrich M, Mann E, Kutuzov MA, Morotti M, Wietek N, Rada H, Yusuf S, Afrose J, Siokis A, Meyer-Hermann M, Ahmed AA, Depoil D, Dustin ML. A dynamic CD2-rich compartment at the outer edge of the immunological synapse boosts and integrates signals. Nat Immunol. 2020;21(10):1232-\u0080\u009343.","DOI":"10.1038\/s41590-020-0770-x"},{"key":"34","doi-asserted-by":"crossref","unstructured":"Stubenvoll A, Schmidt M, Moeller J, Chango MAL, Schultz C, Antoniadou O, Loeffler-Wirth H, Bernhart S, Gro\u00dfe F, Thier B, Paschen A, Anderegg U, Simon JC, Ziemer M, Schoeder CT, Binder H, Kunz M. Single-cell transcriptomics and epigenomics point to CD58-CD2 interaction in controlling primary melanoma growth and immunity. Cancer Commun. 2025;45(4):465-\u0080\u009370.","DOI":"10.1002\/cac2.12651"},{"key":"35","doi-asserted-by":"crossref","unstructured":"Challa-Malladi M, Lieu YK, Califano O, Holmes AB, Bhagat G, Murty VV, Dominguez-Sola D, Pasqualucci L, Dalla-Favera R. Combined genetic inactivation of \u00ce\u00b22-Microglobulin and CD58 reveals frequent escape from immune recognition in diffuse large B cell lymphoma. Cancer Cell. 2011;20(6):728-\u0080\u009340.","DOI":"10.1016\/j.ccr.2011.11.006"},{"key":"36","doi-asserted-by":"crossref","unstructured":"Zhang Y, Liu Q, Yang S, Liao Q. CD58 immunobiology at a glance. Front Immunol. 2021;12:705260.","DOI":"10.3389\/fimmu.2021.705260"},{"key":"37","doi-asserted-by":"crossref","unstructured":"Scheibenbogen C, Keilholz U, Meuer S, Dengler T, Tilgen W, Hunstein W. Differential expression and release of LFA-3 and ICAM-1 in human melanoma cell lines. Int J Cancer. 1993;54(3):494-\u0080\u00938.","DOI":"10.1002\/ijc.2910540323"},{"key":"38","doi-asserted-by":"crossref","unstructured":"Ge EJ, Bush AI, Casini A, Cobine PA, Cross JR, DeNicola GM, Dou QP, Franz KJ, Gohil VM, Gupta S, Kaler SG, Lutsenko S, Mittal V, Petris MJ, Polishchuk R, Ralle M, Schilsky ML, Tonks NK, Vahdat LT, Van Aelst L, Xi D, Yuan P, Brady DC, Chang CJ. Connecting copper and cancer: From transition metal signalling to metalloplasia. Nat Rev Cancer. 2022;22(2):102-\u0080\u009313.","DOI":"10.1038\/s41568-021-00417-2"},{"key":"39","doi-asserted-by":"crossref","unstructured":"Shanbhag VC, Gudekar N, Jasmer K, Papageorgiou C, Singh K, Petris MJ. Copper metabolism as a unique vulnerability in cancer. Biochim Biophys Acta Mol Cell Res. 2021;1868(2):118893.","DOI":"10.1016\/j.bbamcr.2020.118893"},{"key":"40","doi-asserted-by":"crossref","unstructured":"Leone N, Courbon D, Ducimetiere P, Zureik M. Zinc, copper, and magnesium and risks for all-cause, cancer, and cardiovascular mortality. Epidemiology. 2006;17(3):308-\u0080\u009314.","DOI":"10.1097\/01.ede.0000209454.41466.b7"},{"key":"41","doi-asserted-by":"crossref","unstructured":"Guan D, Zhao L, Shi X, Ma X, Chen Z. Copper in cancer: From pathogenesis to therapy. Biomed Pharmacother. 2023;163:114791.","DOI":"10.1016\/j.biopha.2023.114791"},{"key":"42","doi-asserted-by":"crossref","unstructured":"Wu Z, Lv G, Xing F, Xiang W, Ma Y, Feng Q, Yang W, Wang H. Copper in hepatocellular carcinoma: A double-edged sword with therapeutic potentials. Cancer Lett. 2023;571:216348.","DOI":"10.1016\/j.canlet.2023.216348"},{"key":"43","doi-asserted-by":"crossref","unstructured":"Zhou C, Yang J, Liu T, Jia R, Yang L, Sun P, Zhao W. Copper metabolism and hepatocellular carcinoma: Current insights. Front Oncol. 2023;13:1186659.","DOI":"10.3389\/fonc.2023.1186659"}],"container-title":["Critical Reviews in Eukaryotic Gene Expression"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.dl.begellhouse.com\/download\/article\/146a181b23a72fbb\/CRE-63933.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T19:16:49Z","timestamp":1785352609000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.dl.begellhouse.com\/journals\/6dbf508d3b17c437,320bc5320bccf579,146a181b23a72fbb.html"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026]]},"references-count":43,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1615\/critreveukaryotgeneexpr.2026063933","relation":{},"ISSN":["1045-4403"],"issn-type":[{"value":"1045-4403","type":"print"}],"subject":[],"published":{"date-parts":[[2026]]}}}